T2DM Clinical Trial
Official title:
A Phase I Study to Evaluate the Drug-Drug Interaction of Chiglitazar With Empagliflozin，Atorvastatin and Valsartan in Healthy Subjects.
This Phase 1 open label study is being conducted to characterize the pharmacokinetic (PK) and safety profiles of Chiglitazar with Empagliflozin，Atorvastatin and Valsartan in healthy subjects.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT04544319 -
Clinical Trial to Compare the PK of the Fixed-dose Combinations and Each Component of Gemigliptin/Dapagliflozin 50/10 mg
|
Phase 1 | |
| Recruiting |
NCT05996380 -
A Phase 1 Trial to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3167 Single Injection in Healthy Subjects and Patients With Type 2 Diabetes
|
Phase 1 | |
| Recruiting |
NCT02037100 -
Sleep Disordered Breathing and Impaired Glucose Homeostasis in Obese Children
|
N/A | |
| Recruiting |
NCT03563794 -
Efficacy and Safety of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion in Uncontrolled Type 2 Diabetes
|
Phase 4 | |
| Completed |
NCT01990469 -
Efficacy and Safety of Gemigliptin 50mg qd Added in Patients With Type 2 Diabetes Inadequately Controlled on Glimepiride and Metformin
|
Phase 3 | |
| Active, not recruiting |
NCT05680129 -
A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM
|
Phase 3 | |
| Active, not recruiting |
NCT04609631 -
Tai Chi for Comorbid Depression in T2DM Patients
|
N/A | |
| Active, not recruiting |
NCT05680155 -
A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients
|
Phase 3 | |
| Recruiting |
NCT03564431 -
The Imaging Genetic Study of Type 2 Diabetes and Depression
|
||
| Recruiting |
NCT05159882 -
Safety and Efficacy of THR-1442 Compared to Dapagliflozin as Add-on Therapy to Metformin in T2DM
|
Phase 3 |